株式会社極東書店トップ ＞ 商品一覧 ＞ Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation. 2024 ed.
商品詳細
Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation. 2024 ed.
・ISBN 978-3-031-53658-8 hard EUR 129.99
￥34,745.- (税込) ※（※）価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。
お気に入り
★★★
| 著者・編者 | Alizadehasl, Azin / Ghavamzadeh, Ardeshir / Emami, Amir Hossein / Janbabaei, Ghasem / Khoda-Amorzideh, Davood (eds.), |
|---|---|
| 出版社 | (Springer International Publishing AG, SZ) |
| 出版年月 | 2024 |
| ページ数 | 291 pp. |
| 言語 | ENG |
| ニュース番号 | ＜A02-20816＞ |
解説
This book discusses the epidemiology and the known cardiotoxic effects of chemoradiation agents in addition to newer therapies in hematopoietic stem cell transplantation (HSCT). Recent expert consensus statements from cardiology and hematology/oncology societies are reviewed in regard to risk stratification of the patient based on the type of treatments they are undergoing. Finally, gaps in knowledge are identified with proposed avenues of research that allow for more accurate risk assessment, prediction and potential treatment of the HSCT patient in attenuating the risk of developing cardiovascular comorbidities.
Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation reveals a picture of effective management of these patients in order to optimize both short- and long-term outcomes of HSCT. It is of considerable interest to all involved or training within this rapidly growing area of cardiology and oncology.
Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation reveals a picture of effective management of these patients in order to optimize both short- and long-term outcomes of HSCT. It is of considerable interest to all involved or training within this rapidly growing area of cardiology and oncology.